subject: Sanofi - Aventis Pharma Livelihood Enterprises Set Up Health Drugs - Sanofi - Pharmaceutical [print this page] Sanofi - Aventis Europe (Stock code: SAN, NYSE: SNY) and Hangzhou Minsheng Pharmaceutical Co., Ltd. today signed a formal trade contract, together to form a new joint venture area of health medicine. Depends on the transaction-related preconditions and government approval, Sanofi - Aventis will be the majority of the equity joint venture. Hangzhou main leaders of both present and witnessed the signing ceremony.
Sanofi - Aventis Pharma, a joint venture with the people's livelihood will be the main production and management Vitamin And mineral products. Vitamin and mineral products is the largest OTC market in a category, people's livelihood and medicine, with its flagship brand VITA 21 gold?, Has been in the field has considerable strength. Sanofi - Aventis is the world's fifth largest non-prescription drug business and continued through mergers and acquisitions, expand its global health medicine in the field strength. Most recently, Sanofi - Aventis announced plans to acquire Chattem Inc., to take direct participation in the health of the U.S. pharmaceutical market. U.S. share of global health pharmaceutical market share of 25%. Chattem, Inc. is the nation's leading health medicine brand name products, toiletries and dietary nutrition of manufacturers and dealers.
Sanofi - Aventis Group, president of Global Operations HanspeterSpek attended the signing ceremony, and said: "The two sides signed a formal trade contract marks the Sanofi - Aventis with many years Cooperation Minsheng Pharmaceutical Partners --- the common goal of a new step towards a crucial step. Into China, the world's second largest OTC market is Sanofi - aventis medicine in the health field strength of the strategic expansion initiatives. Sanofi - Aventis to become focused on the diversity of the health needs of Chinese people Medicine Health business, we especially hope to contribute to the cause of preventive medicine. We in China have led the vaccine market has advantages. Access to health pharmaceutical market will become another pillar of support for preventive medicine. "
Hangzhou Minsheng Pharmaceutical Co., Ltd. Chairman Zhu Fujiang said: "We and Sanofi - Aventis has 10 years of happy co-operation in history. The new health medicine fields are exciting event. Sanofi - aventis is a highly dynamic and viable enterprises, the success of prescription drugs and vaccines have been amply demonstrated its Marketing Ability, we hope that the new projects of cooperation, make the people's livelihood medicine vitamin products to cover all markets, so that more people enjoy health protection, but also hope the project platform to develop more and more comprehensive Health Products, bring in more and better for the consumer health protection services while contributing to local economic development. "
2008, China's OTC market size of about 70 million euros (about 70 billion yuan), and is expected to maintain double-digit growth the next five years, including positive factors include: the ability of consumers to pay increased gradually; governments increasingly focus on health awareness and disease prevention, to further promote the self-care; and pharmacy chains and the rapid development of modern commerce.
